In today’s highly regulated environment, life sciences companies are investing significantly in their compliance programs. Part of this investment may include technology that leverages data and information about third parties, interactions with health care professionals, and spend information from health care professionals/health care organizations. As a result, a company’s compliance arm is data rich, but the information has primarily been leveraged for risk assessments, comparative analysis, reporting and monitoring purposes.
This webcast will explore how your company’s enormous stockpile of data, both publically available and proprietary, might be used in high-value ways, not only for future risk planning purposes but also to help unlock answers to some of your key business issues and challenges.
- Describe how large and midsize life sciences leaders are optimizing their approach by strategically using data analytics for competitive advantage to protect their reputations and maintain a solid standing with health authorities and the OIG
- Demonstrate how to build a global lens into analytics by combining existing internal data sources (compliance and others) with external data sources (structured and unstructured data)
Review the discussion and learn more: download the PDF.
Recommended field of study: Business management and organization
Program level: Overview
Delivery method: Group-internet
If you have any questions or encounter any difficulties while enrolling, please contact technical support via phone at +1 877 398 9939, via email at GTWebcast@level3.com or visit our webcasting frequently asked questions page.
If you have any questions regarding CPE credit, please contact CPE support via phone at +1 630 396 5831, via email at CPEEvents@us.gt.com or visit our webcast CPE information page.